scispace - formally typeset
Open AccessJournal ArticleDOI

Tumor evolution: Linear, branching, neutral or punctuated?☆

TLDR
Data is discussed that supports the theory that most human tumors evolve from a single cell in the normal tissue, and suggests that models may change during tumor progression or operate concurrently for different classes of mutations.
About
This article is published in Biochimica et Biophysica Acta.The article was published on 2017-04-01 and is currently open access. It has received 255 citations till now. The article focuses on the topics: Tumor progression.

read more

Citations
More filters

SF-010-4 Distant metastasis occurs late during the genetic evolution of pancreatic cancer

TL;DR: A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell.
Journal ArticleDOI

Epigenetic plasticity and the hallmarks of cancer

TL;DR: It is proposed that chromatin and epigenetic aberrations have the potential to confer on cells the full range of oncogenic properties represented in the classic “hallmarks” depiction of cancer, and it is suggested that genetic, environmental, and metabolic factors can make chromatin aberrantly permissive or restrictive.
Journal ArticleDOI

Eleven grand challenges in single-cell data science

David Lähnemann, +71 more
- 07 Feb 2020 - 
TL;DR: This compendium is for established researchers, newcomers, and students alike, highlighting interesting and rewarding problems for the coming years in single-cell data science.
Journal ArticleDOI

Tumour heterogeneity and metastasis at single-cell resolution.

TL;DR: Recent advances in single-cell technologies are reviewed and discussed in detail how they can be leveraged to understand tumour heterogeneity and metastasis.

Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity

TL;DR: The analysis of cellular heterogeneity for genetic and phenotypic features and their spatial distribution in breast tumors pre- and post-neoadjuvant chemotherapy found that intratumor genetic diversity was tumor-subtype specific, and it did not change during treatment in tumors with partial or no response.
References
More filters
Journal ArticleDOI

Evolving responsively: adaptive mutation

TL;DR: The emerging mechanisms of adaptive genetic change cast evolution, development and heredity into a new perspective, indicating new models for the genetic changes that fuel these processes.
Journal ArticleDOI

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer

TL;DR: Clinical support for an emerging paradigm in cancer immunotherapy, wherein optimal use of vaccination might be more effective, not as a separate modality, but in direct combination with chemotherapy, is provided.
Journal ArticleDOI

Punctuated copy number evolution and clonal stasis in triple-negative breast cancer

TL;DR: A highly multiplexed single-nucleus sequencing method is developed to investigate copy number evolution in patients with triple-negative breast cancer, showing that the majority of copy number aberrations are acquired at the earliest stages of tumor evolution, in short punctuated bursts that form the tumor mass.
Journal ArticleDOI

PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors

TL;DR: A principled phylogenic correction for VAFs in loci affected by copy number alterations is introduced and it is shown that this correction greatly improves subclonal reconstruction compared to existing methods.
Related Papers (5)